Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
1. Although after treatment for breast cancer such as chemotherapy or hormonal therapy,
urogenital atrophy is common, the patients are seldomly treated for several reasons.
Management of this problem is important for improving quality of life.
2. "Clino-san" is a kind of vaginal lubricant with pH 5 which is similar pH of
premenopausal vaginal discharge. After randomization of patients, they are treated with
Clino-san or placebo 3 times/week for 12 weeks.
3. We check the vaginal symptoms, vag dryness severity score, and ultrasonography at
baseline, 4, 8, and 12 weeks of treatment.